Why PCOS is being recast as a wider metabolic health threat

Doctors are increasingly highlighting the links between insulin resistance, excess androgen production and the heightened risks of diabetes, heart disease and endometrial cancer in women with PCOS.

Polycystic ovary syndrome, now increasingly described as polyendocrine metabolic ovarian syndrome or PMOS, is best understood not only as a reproductive disorder but also as a metabolic one, according to Samantha Schon, an obesity medicine-certified physician, reproductive endocrinologist and associate professor at the University of Michigan. Schon said the condition is driven mainly by insulin resistance and hyperandrogenism, meaning the body struggles to respond properly to insulin while producing excess androgens, the hormones that are higher in women with PMOS than in women without the condition.

That interaction helps explain why PMOS can affect far more than menstrual regularity. Mayo Clinic and Johns Hopkins Medicine both note that insulin resistance can push insulin levels higher, which in turn can stimulate more androgen production and worsen symptoms such as acne, unwanted hair growth, scalp hair thinning and irregular periods. In practice, that hormonal feedback loop can make symptoms more persistent while also amplifying the wider metabolic burden.

The metabolic consequences can be serious. When insulin resistance keeps blood sugar elevated over time, it raises the risk of prediabetes and type 2 diabetes. Research cited in the source material suggests that about 70% of women with PMOS have insulin resistance, while the proportion may be even higher among women with obesity. StatPearls also describes PMOS as the most common endocrine disorder in women of reproductive age, affecting between 5% and 26% of that group worldwide.

The long-term health risks extend beyond diabetes. The US Centres for Disease Control and Prevention says about half of women with PMOS develop type 2 diabetes by the age of 40, while Johns Hopkins Medicine and Cleveland Clinic note increased risks of high blood pressure, abnormal cholesterol levels, heart disease and endometrial cancer. That is why specialists increasingly frame PMOS as a condition that demands metabolic as well as hormonal management, with diet, physical activity, sleep and weight management often discussed alongside medical treatment.